Brain Tumor Pathology

, Volume 28, Issue 2, pp 157–161 | Cite as

Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas

  • Makoto Okada
  • Hirohito Yano
  • Yoshinobu Hirose
  • Noriyuki Nakayama
  • Naoyuki Ohe
  • Jun Shinoda
  • Toru Iwama
Case Report

Abstract

A 42-year-old woman had suffered from headaches since April 2009. Computed tomography revealed a tumor with marked calcification in the left frontal lobe adjacent to the left anterior horn of the lateral ventricle. T1-weighted gadolinium-enhanced magnetic resonance imaging showed a well-enhanced tumor at the lesion. Dynamic methionine positron emission tomography showed no delayed methionine attenuation. Initial preoperative diagnosis was extraventricular neurocytoma (EVN). However, oligodendroglioma was determined upon a second diagnosis. The patient underwent total tumor removal. Hematoxylin and eosin staining showed the characteristic fried egg-like cells, round nuclei, and immunohistochemically, the tumor cells were positive for glial fibrillary acidic protein, synaptophysin, neuronal nuclear antigen, microtubule-associated protein 2 and Olig2. The MIB-1 labeling index was 20%, which suggested malignancy. Although these findings demonstrated that the tumor had glioneuronal character, it was difficult to differentiate between EVN and oligodendroglioma. There have been reports that Olig2 immunohistochemistry is generally positive in cases of oligodendroglioma, but not in cases of neurocytoma. We completed the diagnosis as oligodendroglioma. Subsequent electron microscopy results presented oligodendroglial but not neuronal characteristics. We concluded that Olig2 is useful in the differential diagnosis of oligodendrogliomas and EVNs.

Keywords

Olig2 Electron microscopy Oligodendroglioma Extraventricular neurocytoma 

References

  1. 1.
    Figarella-Branger D, Soylemezoglu F, Burger PC (2007) Central neurocytoma and extraventricular neurocytoma. In: Louis DN, Ohgaki H, Otmar D (eds) The 2007 WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, pp 106–109Google Scholar
  2. 2.
    Giangaspero F, Cenacchi G, Losi L et al (1997) Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol 21:206–212PubMedCrossRefGoogle Scholar
  3. 3.
    Brat DJ, Scheithauer BW, Eberhart CG et al (2001) Extraventricular neurocytomas: pathologic features and clinical outcome. J Surg Pathol 25:1252–1260CrossRefGoogle Scholar
  4. 4.
    Shinoda J, Yano H, Yoshimura S et al (2003) Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 99:597–603PubMedCrossRefGoogle Scholar
  5. 5.
    McLendon RE, Enterline DS, Tien RD, Thorstad WL, Bruner JM (1998) Tumors of central neuroepithelial origin. In: Binger DD, McLendon RE, Bruner JM (eds) Russell and Rubinstein’s pathology of tumors of the nervous system, 4th edn. Arnold, London, pp 370–387Google Scholar
  6. 6.
    Lantos PL, VandenBerg SR, Kleihues P (1997) Oligodendroglial tumours. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology, 4th edn. Arnold, London, pp 627–636Google Scholar
  7. 7.
    Reifenberger G, Kros JM, Louis DN, Collins VP (2007) Oligodendroglial tumours. In: Louis DN, Ohgaki H, Otmar D (eds) The 2007 WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, pp 53–67Google Scholar
  8. 8.
    Yang GF, Wu SY, Zhang LJ et al (2009) Imaging findings of extraventricular neurocytoma: report of 3 cases and review of the literature. AJNR Am J Neuroradiol 30:581–585PubMedCrossRefGoogle Scholar
  9. 9.
    Nakayama N, Shinoda J, Yano H et al (2009) PET analysis of glioma: differences between astrocytic tumors and oligodendrocytic tumors using choline, FDG, and methionine PET. Prog CI 31:83–90 (in Japanese)Google Scholar
  10. 10.
    Mrak RE, Yasargil MG, Mohapatra G et al (2004) Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss. Hum Pathol 35:1156–1159PubMedCrossRefGoogle Scholar
  11. 11.
    Perry A, Scheithauer BW, Macaulay RJB et al (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61:947–955PubMedGoogle Scholar
  12. 12.
    Ng HK, Ko HCW, Tse CCH et al (1994) Immunohistochemical and ultrastructural studies of oligodendrogliomas revealed features of neuronal differentiation. Int J Surg Pathol 2:47–56Google Scholar
  13. 13.
    Yano H, Ohe N, Shinoda J et al (2009) Immunohistochemical study concerning the origin of neurocytoma—a case report. Pathol Oncol Res 15:301–305Google Scholar
  14. 14.
    Lu QR, Yuk D, Alberta JA et al (2000) Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25:317–329PubMedCrossRefGoogle Scholar
  15. 15.
    Zhou Q, Wang S, Anderson DJ (2000) Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25:331–343PubMedCrossRefGoogle Scholar
  16. 16.
    Yokoo H, Nobusawa S, Takebayashi H et al (2004) Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717–1725PubMedCrossRefGoogle Scholar
  17. 17.
    Kubota T, Hayashi M, Kawano H et al (1991) Differential diagnosis of oligodendrogliomas: immunohistochemical and ultrastructural study. Brain Tumor Pathol 8:17–24Google Scholar
  18. 18.
    Iida M, Tsujimoto S, Nakayama H et al (2008) Ultrastructural study of neuronal and related tumors in the ventricles. Brain Tumor Pathol 25:19–23PubMedCrossRefGoogle Scholar
  19. 19.
    Okamoto Y, Di Patre PL, Burkhard C et al (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108:49–56PubMedCrossRefGoogle Scholar
  20. 20.
    Moriguchi S, Yamashita A, Marutsuka K et al (2006) Atypical extraventricular neurocytoma. Pathol Int 56:25–29PubMedCrossRefGoogle Scholar

Copyright information

© The Japan Society of Brain Tumor Pathology 2011

Authors and Affiliations

  • Makoto Okada
    • 1
    • 4
  • Hirohito Yano
    • 1
  • Yoshinobu Hirose
    • 2
  • Noriyuki Nakayama
    • 1
  • Naoyuki Ohe
    • 1
  • Jun Shinoda
    • 3
  • Toru Iwama
    • 1
  1. 1.Department of NeurosurgeryGifu University Graduate School of MedicineGifuJapan
  2. 2.Department of PathologyGifu University Graduate School of MedicineGifuJapan
  3. 3.Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Department of NeurosurgeryKizawa Memorial HospitalMinokamoJapan
  4. 4.Department of NeurosurgeryHashima City HospitalHashimaJapan

Personalised recommendations